Cardiff Oncology Inc. buy secretariat
Start price
19.09.20
/
50%
€7.40
Target price
23.09.20
-
Performance (%)
34.46%
End price
23.09.20
€9.95
Summary
This prediction ended on 23.09.20 with a price of €9.95. The BUY prediction by secretariat for Cardiff Oncology Inc. saw massive gains of 34.46%. secretariat has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -14.417% | -14.417% | 93.424% | -60.898% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
According to secretariat what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by secretariat for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Buy beendet